4//SEC Filing
Harris Melody 4
Accession 0001077183-25-000002
CIK 0001077183other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:11 PM ET
Size
21.1 KB
Accession
0001077183-25-000002
Insider Transaction Report
Form 4
Harris Melody
Chf Ops Off, Pres, Informatics
Transactions
- Tax Payment
Common Stock
2025-01-01−7,070→ 102,820 total
Holdings
- 201,613
Stock Option (Right to Buy)
Exercise: $9.24Exp: 2030-01-01→ Common Stock (201,613 underlying) - 21,204
Performance Stock Unit
Exercise: $0.00From: 2026-05-11→ Common Stock (21,204 underlying) - 42,344
Stock Option (Right to Buy)
Exercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying) - 25,329
Restricted Stock Unit
Exercise: $0.00→ Common Stock (25,329 underlying) - 19,984
Stock Option (Right to Buy)
Exercise: $13.96Exp: 2034-05-02→ Common Stock (19,984 underlying) - 11,939
Performance Stock Unit
Exercise: $0.00From: 2027-05-02→ Common Stock (11,939 underlying) - 14,136
Restricted Stock Unit
Exercise: $0.00→ Common Stock (14,136 underlying) - 25,330
Performance Stock Unit
Exercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying) - 39,683
Stock Option (Right to Buy)
Exercise: $19.65Exp: 2030-05-11→ Common Stock (39,683 underlying) - 11,939
Restricted Stock Unit
Exercise: $0.00→ Common Stock (11,939 underlying)
Footnotes (13)
- [F1]Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the January 1, 2025 vesting of restricted stock.
- [F10]On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- [F11]On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F12]On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F13]On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- [F2]This balance includes 1,589 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
- [F3]On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F5]On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F6]Once vested, the shares of common stock are not subject to expiration.
- [F7]On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
- [F8]On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F9]On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001880847
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:11 PM ET
- Size
- 21.1 KB